Highlights Two abstracts on Clarity's diagnostic COBRA and CLARIFY trials with 64Cu-SAR-bisPSMA have been accepted for presentation at the American Society of Clinical Oncology Genitourinary Cancers ...
Artificial intelligence startup Quibim has raised $50 million in first-round financing to support the rollout of its ...
A study of men with a family history of prostate cancer has discovered an inherited form of prostate cancer. The inherited ...
I am a 66-year-old white male who is active and relatively healthy. I have recently been diagnosed with prostate cancer. One ...
Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has completed the acquisition of ...
MELBOURNE, Australia and INDIANAPOLIS, Jan. 28, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces ...